研究论文
CRISPR-Cas13d Multiplexed Diagnostics for Simultaneous Detection of 12 Emerging Viral Pathogens in Under 30 Minutes
文章指标
摘要
Rapid identification of emerging viral threats is critical for pandemic preparedness. Current diagnostic platforms are either fast but detect single targets (lateral flow assays) or comprehensive but slow (metagenomic sequencing). We present ViralSHIELD, a CRISPR-Cas13d-based multiplexed diagnostic system that simultaneously detects 12 high-priority viral pathogens — including SARS-CoV-2 variants, influenza A/B, RSV, MERS-CoV, Nipah, Ebola, Zika, and dengue serotypes — from a single nasopharyngeal swab in 28 minutes. The assay uses isothermal recombinase polymerase amplification (RPA) coupled with Cas13d collateral cleavage of orthogonal fluorescent reporters. Clinical validation on 2,450 patient samples across three hospital sites achieves 97.8% sensitivity and 99.4% specificity relative to RT-qPCR.